A detailed history of Nilsine Partners, LLC transactions in Danaher Corp stock. As of the latest transaction made, Nilsine Partners, LLC holds 1,948 shares of DHR stock, worth $467,520. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,948
Previous 2,229 12.61%
Holding current value
$467,520
Previous $516 Million 5.66%
% of portfolio
0.07%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$224.58 - $256.19 $63,106 - $71,989
-281 Reduced 12.61%
1,948 $486 Million
Q4 2023

Jan 24, 2024

SELL
$185.1 - $233.13 $2.31 Million - $2.92 Million
-12,504 Reduced 84.87%
2,229 $516 Million
Q3 2023

Nov 01, 2023

BUY
$233.08 - $265.59 $28,668 - $32,667
123 Added 0.84%
14,733 $3.66 Billion
Q2 2023

Jul 21, 2023

SELL
$224.99 - $256.14 $21,599 - $24,589
-96 Reduced 0.65%
14,610 $3.51 Billion
Q1 2023

May 10, 2023

BUY
$239.75 - $277.0 $3.53 Million - $4.07 Million
14,706 New
14,706 $3.71 Billion

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $175B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Nilsine Partners, LLC Portfolio

Follow Nilsine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nilsine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nilsine Partners, LLC with notifications on news.